This webinar, presented by Olivier Barberan, Director, Translational Medicine Solutions at Elsevier will cover tools and best practices when using a static approach to DDI predictions to support drug submission and labeling.

Topics to be covered:
• Regulatory guidance to predict DDI (FDA, EMA, DMDA)
• Types of questions asked by regulatory agencies and how to answer them
• Use, added value and limitation of mechanistic approach and PB/PK during drug development

The format of this webinar will be a 35 minute presentation followed by a Q&A session

Part of the PharmaPendium Webinar Series: Risk Assessment in Drug Development